| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jul 09, 2026 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$86.00
Est. +33%
|
$64.50 | $70.35 |
Pending
|
$54.01
-16.3%
|
| Feb 24, 2026 |
Vir Biotechnology Inc
VIR
|
BUY |
$18.00
Est. +87%
|
$9.64 | $11.66 |
Pending
|
$9.35
-3.0%
|
| Feb 11, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$170.00
Est. +10%
|
$154.09 | $157.27 |
Pending
|
$130.34
-15.4%
|
| Mar 26, 2024 |
Stoke Therapeutics Inc
STOK
|
BUY |
$22.00
Est. +238%
|
$6.50 | $16.15 |
Miss
|
$28.96
+345.5%
|
| Jan 05, 2024 |
Phathom Pharmaceuticals Inc
PHAT
|
BUY |
$26.00
Est. +189%
|
$8.99 | $19.71 |
Miss
|
$11.70
+30.1%
|
| May 19, 2022 |
Zealand Pharma A/S. - ADR
ZEAL
|
BUY |
$32.00
Est. +132%
|
$13.78 | $18.07 |
Miss
|
$17.59
+27.6%
|
| May 06, 2022 |
Vir Biotechnology Inc
VIR
|
BUY |
$35.00
Est. +60%
|
$21.87 | - | - |
$9.35
-57.2%
|
| Mar 03, 2022 |
Cara Therapeutics Inc
CARA
|
BUY |
$26.00
Est. +135%
|
$11.08 | $502.74 |
Target Met
|
$5.32
-52.0%
|
| Feb 24, 2022 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$60.00
Est. +85%
|
$32.49 | - | - |
$54.01
+66.2%
|